Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0IFSRT
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
cN115160403A B13
|
|||||
| Synonyms |
B13
Click to Show/Hide
|
|||||
| Organization |
BIOBRICS LIFE SCI (NANTONG) CO LTD
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
1-8
|
|||||
| Structure |
|
|||||
| Antibody Name |
Undisclosed
|
Antigen Name |
Undisclosed
|
|||
| Payload Name |
(4-NH2)-Exatecan
|
Payload Info | ||||
| Therapeutic Target |
DNA topoisomerase I (TOP1)
|
Target Info | ||||
| Linker Name |
CN115160403A+B11+Linker
|
Linker Info | ||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||